首页> 外文期刊>Bulletin of the Korean Chemical Society >4-[(N-Imidazol-2-ylmethyl)anilino]pyranopyridine Analogs as Novel Anti-Angiogenic Agents
【24h】

4-[(N-Imidazol-2-ylmethyl)anilino]pyranopyridine Analogs as Novel Anti-Angiogenic Agents

机译:4-[( N -咪唑-2-基甲基)苯胺基]吡喃吡啶类似物作为新型抗血管生成剂

获取原文
           

摘要

We attempted to replace a benzopyran ring of 4-[(N-imidazol-2-ylmethyl)-4-chloroanilino]benzopyran, previously discovered as anti-angiogenic agent with antitumor activity, with pyranopyridines. The [3,2-c]-, [3,2-b]-, [2,3-c]-, and [2,3-b]-pyranopyridines with N-(imidazol-2-ylmethyl)aniline moiety at the 4-position, were synthesized respectively, and evaluated for primary anti-angiogenic properties through primary cultured HUVEC tube formation assay. From this study, we found that the pyranopyridine ring, especially [3,2-b]- and [2,3-c]-isomer, can replace the benzopyran ring of the compound 1 and can be optimized through the introduction of substituents both on the pyranopyridine ring and the aniline moiety for the identification of a novel anti-angiogenic agent.
机译:我们试图用吡喃并吡啶取代4-[((N-咪唑-2-基甲基)-4-氯苯胺基]苯并吡喃的苯并吡喃环,先前发现它是具有抗肿瘤活性的抗血管生成剂。具有N-(咪唑-2-基甲基)苯胺部分的[3,2-c]-,[3,2-b]-,[2,3-c]-和[2,3-b]-吡喃吡啶分别合成4-位上的α,β-氨基丁酸,并通过原代培养的HUVEC管形成试验评估其主要的抗血管生成特性。从这项研究中,我们发现吡喃并吡啶环,尤其是[3,2-b]-和[2,3-c]-异构体可以取代化合物1的苯并吡喃环,并且可以通过引入两个取代基进行优化在吡喃吡啶环和苯胺部分上用于鉴定新型抗血管生成剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号